However, even such a small number of samples shows that the concentration of the investigated biomarkers is significantly higher in the case of ovarian cancer and endometrial cyst than in the controls, and that CA125 determination in plasma can be used to distinguish between ovarian cancer and endometrial cyst. This evidence concerns the gene MUC16 and ovarian carcinoma.